Cardiac valve diseases and antiphospholipid syndrome.

Antiphospholipid syndrome (APS) has been recognized as one of the most commontypes of thrombophilia (1). Its main clinical features are arterial/venous thrombosis and pregnancy loss associated with placenta thrombosis. However, other heterogeneous clinical manifestations may be associated with APS, such as thrombocytopenia, haemolytic anemia, neurological impairment and pulmonary hypertension (2). Morita et al (3) reported an interesting case presenting congestive heart failure with mitral/aortic regurgitation and positivity for antiphospholipid antibodies (aPLs).